Susquehanna International Group, LLP Curis Inc Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 11, 2023	BUY	$0.57 - $0.99 $35,568 - $61,776	62,400 Added 48.86%	190,100 $157,000
Q1 2023 May 16, 2023	SELL	$0.51 - $0.78 $6,222 - $9,516	-12,200 Reduced 8.72%	127,700 $76,000
Q4 2022 Feb 14, 2023	SELL	$0.47 - $17.22 $21,197 - $776,622	-45,100 Reduced 24.38%	139,900 $76,000
Q3 2022 Nov 14, 2022	BUY	$0.74 - $15.01 $25,604 - $519,346	34,600 Added 23.01%	185,000 $130,000
Q2 2022 Aug 15, 2022	BUY	$0.71 - $2.43 $89,673 - $306,909	126,300 Added 524.07%	150,400 $147,000
Q1 2022 May 16, 2022	SELL	$2.31 - $5.13 $67,683 - $150,309	-29,300 Reduced 54.87%	24,100 $57,000
Q4 2021 Feb 14, 2022	SELL	$4.45 - $8.09 $529,550 - $962,710	-119,000 Reduced 69.03%	53,400 $254,000
Q3 2021 Nov 15, 2021	BUY	$6.94 - $8.85 $626,682 - $799,155	90,300 Added 109.99%	172,400 $1.35 Million
Q2 2021 Aug 11, 2021	SELL	$7.45 - $16.27 $1.46 Million - $3.19 Million	-196,100 Reduced 70.49%	82,100 $663,000
Q1 2021 May 17, 2021	SELL	$8.78 - $12.8 $210,719 - $307,200	-24,000 Reduced 7.94%	278,200 $3.15 Million
Q4 2020 Feb 16, 2021	BUY	$1.08 - $8.2 $313,524 - $2.38 Million	290,300 Added 2439.5%	302,200 $2.48 Million
Q3 2020 Nov 16, 2020	SELL	$0.95 - $1.42 $23,560 - $35,216	-24,800 Reduced 67.57%	11,900 $14,000
Q2 2020 Aug 14, 2020	BUY	$0.63 - $1.7 $15,498 - $41,820	24,600 Added 203.31%	36,700 $44,000
Q2 2019 Aug 14, 2019	SELL	$1.36 - $2.35 $116,688 - $201,630	-85,800 Reduced 87.64%	12,100 $23,000
Q1 2019 May 15, 2019	BUY	$0.78 - $2.01 $53,742 - $138,488	68,900 Added 237.59%	97,900 $195,000
Q4 2018 Feb 14, 2019	BUY	$0.62 - $2.25 $248 - $900	400 Added 1.4%	29,000 $20,000
Q3 2018 Nov 14, 2018	SELL	$1.38 - $1.94 $57,407 - $80,704	-41,600 Reduced 59.26%	28,600 $51,000
Q2 2018 Aug 14, 2018	BUY	$1.73 - $3.35 $121,446 - $235,170	70,200 New	70,200 $121,000

About CURIS INC

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

More about CRIS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account